Acta Pharmaceutica Sinica B,
Journal Year:
2021,
Volume and Issue:
11(12), P. 4045 - 4054
Published: March 27, 2021
Ferroptosis
is
a
non-apoptotic
regulated
cell
death
caused
by
iron
accumulation
and
subsequent
lipid
peroxidation.
Currently,
the
therapeutic
role
of
ferroptosis
on
cancer
gaining
increasing
interest.
Baicalin
an
active
component
in
Cell Death and Disease,
Journal Year:
2020,
Volume and Issue:
11(2)
Published: Feb. 3, 2020
Abstract
Ferroptosis
is
a
new
type
of
cell
death
that
was
discovered
in
recent
years
and
usually
accompanied
by
large
amount
iron
accumulation
lipid
peroxidation
during
the
process;
occurrence
ferroptosis
iron-dependent.
Ferroptosis-inducing
factors
can
directly
or
indirectly
affect
glutathione
peroxidase
through
different
pathways,
resulting
decrease
antioxidant
capacity
reactive
oxygen
species
(ROS)
cells,
ultimately
leading
to
oxidative
death.
Recent
studies
have
shown
closely
related
pathophysiological
processes
many
diseases,
such
as
tumors,
nervous
system
ischemia-reperfusion
injury,
kidney
blood
diseases.
How
intervene
development
diseases
regulating
has
become
hotspot
focus
etiological
research
treatment,
but
functional
changes
specific
molecular
mechanisms
still
need
be
further
explored.
This
paper
systematically
summarizes
latest
progress
research,
with
on
providing
references
for
understanding
its
pathogenesis
proposing
targets
treatment
Autophagy,
Journal Year:
2020,
Volume and Issue:
17(9), P. 2054 - 2081
Published: Aug. 19, 2020
Ferroptosis
is
an
iron-dependent,
non-apoptotic
form
of
regulated
cell
death
caused
by
lipid
peroxidation,
which
controlled
integrated
oxidation
and
antioxidant
systems.
The
iron-containing
enzyme
lipoxygenase
the
main
promoter
ferroptosis
producing
hydroperoxides,
its
function
relies
on
activation
ACSL4-dependent
biosynthesis.
In
contrast,
selenium-containing
GPX4
currently
recognized
as
a
central
repressor
ferroptosis,
activity
depends
glutathione
produced
from
cystine-glutamate
antiporter
SLC7A11.
Many
metabolic
(especially
involving
iron,
lipids,
amino
acids)
degradation
pathways
(macroautophagy/autophagy
ubiquitin-proteasome
system)
orchestrate
complex
ferroptotic
response
through
direct
or
indirect
regulation
iron
accumulation
peroxidation.
Although
detailed
mechanism
membrane
injury
during
remains
mystery,
ESCRT
III-mediated
plasma
repair
can
make
cells
resistant
to
ferroptosis.
Here,
we
review
recent
rapid
progress
in
understanding
molecular
mechanisms
focus
epigenetic,
transcriptional,
posttranslational
this
process.Abbreviations:
2ME:
beta-mercaptoethanol;
α-KG:
α-ketoglutarate;
ccRCC:
clear
renal
carcinoma;
EMT:
epithelial-mesenchymal
transition;
FAO:
fatty
acid
beta-oxidation;
GSH:
glutathione;
MEFs:
mouse
embryonic
fibroblasts;
MUFAs:
monounsaturated
acids;
NO:
nitric
oxide;
NOX:
NADPH
oxidase;
PPP:
pentose
phosphate
pathway;
PUFA:
polyunsaturated
acid;
RCD:
death;
RNS:
reactive
nitrogen
species;
ROS:
oxygen
RTAs:
radical-trapping
antioxidants;
UPS:
system;
UTR:
untranslated
region.
Signal Transduction and Targeted Therapy,
Journal Year:
2021,
Volume and Issue:
6(1)
Published: Feb. 3, 2021
Abstract
Ferroptosis
is
an
iron-dependent
cell
death,
which
different
from
apoptosis,
necrosis,
autophagy,
and
other
forms
of
death.
The
process
ferroptotic
death
defined
by
the
accumulation
lethal
lipid
species
derived
peroxidation
lipids,
can
be
prevented
iron
chelators
(e.g.,
deferiprone,
deferoxamine)
small
lipophilic
antioxidants
ferrostatin,
liproxstatin).
This
review
summarizes
current
knowledge
about
regulatory
mechanism
ferroptosis
its
association
with
several
pathways,
including
iron,
lipid,
cysteine
metabolism.
We
have
further
discussed
contribution
to
pathogenesis
diseases
such
as
cancer,
ischemia/reperfusion,
various
neurodegenerative
Alzheimer’s
disease
Parkinson’s
disease),
evaluated
therapeutic
applications
inhibitors
in
clinics.
Molecular Cancer,
Journal Year:
2022,
Volume and Issue:
21(1)
Published: Feb. 12, 2022
Abstract
Ferroptosis
is
an
intracellular
iron-dependent
form
of
cell
death
that
distinct
from
apoptosis,
necrosis,
and
autophagy.
Extensive
studies
suggest
ferroptosis
plays
a
pivotal
role
in
tumor
suppression,
thus
providing
new
opportunities
for
cancer
therapy.
The
development
resistance
to
therapy
remains
major
challenge.
A
number
preclinical
clinical
have
focused
on
overcoming
drug
resistance.
Intriguingly,
has
been
correlated
with
resistance,
inducing
demonstrated
reverse
Herein,
we
provide
detailed
description
the
mechanisms
therapeutic
regulating
reversing
common
therapies,
such
as
chemotherapy,
targeted
immunotherapy.
We
discuss
prospect
challenge
strategy
expect
our
review
could
some
references
further
studies.
International Journal of Biological Sciences,
Journal Year:
2020,
Volume and Issue:
16(13), P. 2430 - 2441
Published: Jan. 1, 2020
Hepatocellular
carcinoma
(HCC)
is
a
highly
heterogeneous
disease,
which
makes
the
prognostic
prediction
challenging.Ferroptosis,
an
iron-dependent
form
of
regulated
cell
death,
can
be
induced
by
sorafenib.However,
value
ferroptosis-related
genes
in
HCC
remains
to
further
elucidated.In
this
study,
mRNA
expression
profiles
and
corresponding
clinical
data
patients
were
downloaded
from
public
databases.The
least
absolute
shrinkage
selection
operator
(LASSO)
Cox
regression
model
was
utilized
construct
multigene
signature
TCGA
cohort.HCC
ICGC
cohort
used
for
validation.Our
results
showed
that
most
(81.7%)
differentially
expressed
between
adjacent
normal
tissues
cohort.Twenty-six
(DEGs)
correlated
with
overall
survival
(OS)
univariate
analysis
(all
adjusted
P<
0.05).A
10-gene
constructed
stratify
into
two
risk
groups.Patients
high-risk
group
significantly
reduced
OS
compared
low-risk
(P
<
0.001
P
=
cohort).The
score
independent
predictor
multivariate
analyses
(HR>
1,
0.01).Receiver
operating
characteristic
(ROC)
curve
confirmed
signature's
predictive
capacity.Functional
revealed
immune-related
pathways
enriched,
immune
status
different
groups.In
conclusion,
novel
gene
HCC.Targeting
ferroptosis
may
therapeutic
alternative
HCC.
Theranostics,
Journal Year:
2021,
Volume and Issue:
11(13), P. 6370 - 6392
Published: Jan. 1, 2021
As
one
of
the
most
important
cancer
treatment
strategies,
conventional
chemotherapy
has
substantial
side
effects
and
leads
easily
to
failure.
Therefore,
exploring
developing
more
efficient
methods
enhance
is
an
urgently
problem
that
must
be
solved.
With
development
nanotechnology,
nanomedicine
showed
a
good
application
prospect
in
improving
chemotherapy.
In
this
review,
we
aim
present
discussion
on
significant
research
progress
for
enhanced
First,
increased
enrichment
drugs
tumor
tissues
relying
different
targeting
ligands
promoting
tissue
penetration
are
summarized.
Second,
specific
subcellular
organelle-targeted
discussed.
Next,
combinational
strategies
reverse
multidrug
resistance
(MDR)
improve
effective
intracellular
concentration
therapeutics
Furthermore,
advantages
combination
therapy
emphasized.
Finally,
discuss
major
problems
facing
therapeutic
chemotherapy,
propose
possible
future
directions
field.
Protein & Cell,
Journal Year:
2021,
Volume and Issue:
12(11), P. 836 - 857
Published: April 23, 2021
Ferroptosis,
an
iron-dependent
form
of
regulated
cell
death
driven
by
peroxidative
damages
polyunsaturated-fatty-acid-containing
phospholipids
in
cellular
membranes,
has
recently
been
revealed
to
play
important
role
radiotherapy-induced
and
tumor
suppression,
mediate
the
synergy
between
radiotherapy
immunotherapy.
In
this
review,
we
summarize
known
as
well
putative
mechanisms
underlying
crosstalk
ferroptosis,
discuss
interactions
ferroptosis
other
forms
induced
radiotherapy,
explore
combination
therapeutic
strategies
targeting
This
review
will
provide
frameworks
for
future
investigations
cancer
therapy.
OncoTargets and Therapy,
Journal Year:
2020,
Volume and Issue:
Volume 13, P. 5429 - 5441
Published: June 1, 2020
Abstract:
Erastin
was
initially
discovered
as
a
small
molecule
compound
that
selectively
kills
tumor
cells
expressing
ST
and
RAS
V12
later
widely
investigated
an
inducer
of
ferroptosis.
Ferroptosis
is
recently
form
cell
death
caused
by
peroxidation
induced
the
accumulation
intracellular
lipid
reactive
oxygen
species
(L-ROS)
in
iron-dependent
manner.
can
mediate
ferroptosis
through
variety
molecules
including
cystine-glutamate
transport
receptor
(system
X
C
−
),
voltage-dependent
anion
channel
(VDAC),
p53.
able
to
enhance
sensitivity
chemotherapy
radiotherapy,
suggesting
promising
future
cancer
therapy.
We
hope
this
review
will
help
better
understand
role
erastin
lay
foundation
for
further
research
development
erastin-based
therapies
future.
Keywords:
erastin,
ferroptosis,
system
,
p53,
VDAC,
Journal of Hematology & Oncology,
Journal Year:
2021,
Volume and Issue:
14(1)
Published: Jan. 20, 2021
Abstract
Background
TNBC
is
the
most
aggressive
breast
cancer
with
higher
recurrence
and
mortality
rate
than
other
types
of
cancer.
There
an
urgent
need
for
identification
therapeutic
agents
unique
mode
action
overcoming
current
challenges
in
treatment.
Methods
Different
inhibitors
were
used
to
study
cell
death
manner
DMOCPTL
.
RNA
silencing
was
evaluate
functions
GPX4
ferroptosis
apoptosis
cells
EGR1
apoptosis.
Immunohistochemical
assay
tissue
microarray
investigating
correlation
TNBC.
Computer-aided
docking
small
molecule
probe
binding
GPX4.
Results
,
a
derivative
natural
product
parthenolide,
exhibited
about
15-fold
improvement
comparing
that
parent
compound
PTL
cells.
The
showed
anti-TNBC
effect
mainly
by
inducing
through
ubiquitination
indicated
induced
directly
protein.
To
best
our
knowledge,
this
first
report
Moreover,
mechanism
regulation
still
obscure.
Here,
we
firstly
reveal
regulated
mitochondria-mediated
Compound
13
prodrug
effectively
inhibited
growth
tumor
prolonged
lifespan
mice
vivo,
no
obvious
toxicity
observed.
Conclusions
These
findings
revealed
novel
induce
provided
up-regulation
deserves
further
studies
as
lead
ultimate
discovery
effective
drug.